HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile.

Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory disease whose pathogenesis and severity correlates with the presence of macrophage-derived pro-inflammatory cytokines within the inflamed synovium. Macrophage-derived cytokines fuel the pathological processes in RA and are targets of clinically successful therapies. However, although macrophage polarization determines cytokine production, the polarization state of macrophages in RA joints remains poorly defined. To dissect the molecular basis for the tissue-damaging effects of macrophages in RA joints, we undertook the phenotypic and transcriptomic characterization of ex vivo isolated CD14(+) RA synovial fluid (RA-SF) macrophages. Flow cytometry and gene profiling indicated that RA-SF macrophages express pro-inflammatory polarization markers (MMP12, EGLN3, CCR2), lack expression of markers associated with homeostatic and anti-inflammatory polarization (IGF1, HTR2B) and exhibit a transcriptomic profile that resembles the activin A-dependent gene signature of pro-inflammatory in vitro-generated macrophages. In fact, high levels of Smad-activating activin A were found in RA-SF and, accordingly, the Smad signalling pathway was activated in ex vivo-isolated RA-SF macrophages. In vitro experiments on monocytes and macrophages indicated that RA-SF promoted the acquisition of pro-inflammatory markers (INHBA, MMP12, EGLN3, CCR2) but led to a significant reduction in the expression of genes associated with homeostasis and inflammation resolution (FOLR2, SERPINB2, IGF1, CD36), thus confirming the pro-inflammatory polarization ability of RA-SF. Importantly, the macrophage-polarizing ability of RA-SF was inhibited by an anti-activin A-neutralizing antibody, thus demonstrating that activin A mediates the pro-inflammatory macrophage-polarizing ability of RA-SF. Moreover, and in line with these findings, multicolour immunofluorescence evidenced that macrophages within RA synovial membranes (RA-SM) also express pro-inflammatory polarization markers whose expression is activin A-dependent. Altogether, our results demonstrate that macrophages from RA synovial fluids and membranes exhibit an MMP12(+) EGLN3(+) CCR2(+) pro-inflammatory polarization state whose acquisition is partly dependent on activin A from the synovial fluid.
AuthorsBlanca Soler Palacios, Lizbeth Estrada-Capetillo, Elena Izquierdo, Gabriel Criado, Concha Nieto, Cristina Municio, Isidoro González-Alvaro, Paloma Sánchez-Mateos, Jose Luis Pablos, Angel L Corbí, Amaya Puig-Kröger
JournalThe Journal of pathology (J Pathol) Vol. 235 Issue 3 Pg. 515-26 (Feb 2015) ISSN: 1096-9896 [Electronic] England
PMID25319955 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Chemical References
  • CCR2 protein, human
  • Lipopolysaccharide Receptors
  • Receptors, CCR2
  • Smad Proteins
  • activin A
  • Activins
  • EGLN3 protein, human
  • Hypoxia-Inducible Factor-Proline Dioxygenases
  • Matrix Metalloproteinase 12
Topics
  • Activins (metabolism)
  • Adult
  • Aged
  • Arthritis, Rheumatoid (metabolism, pathology)
  • Cells, Cultured
  • Female
  • Humans
  • Hypoxia-Inducible Factor-Proline Dioxygenases (metabolism)
  • In Vitro Techniques
  • Inflammation (metabolism, pathology)
  • Lipopolysaccharide Receptors (metabolism)
  • Macrophages (metabolism, pathology)
  • Male
  • Matrix Metalloproteinase 12 (metabolism)
  • Middle Aged
  • Phenotype
  • Receptors, CCR2 (metabolism)
  • Signal Transduction (physiology)
  • Smad Proteins (metabolism)
  • Synovial Membrane (metabolism, pathology)
  • Transcriptome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: